UCB has received a major boost after a Delaware district court confirmed the validity of the company’s patents on one of its major drugs, the anti-seizure drug Vimpat (lacosamide). The case relates to ANDA litigation and involves patent number RE38551 (OB Listed). The court agreed with plaintiffs general characterization of the record: Vimpat® is the result of Dr. Kohn’s decade long […]
Data from the Indian Controller General of Patents, Designs and Trade Marks shows that a total of 1, 45,060 patents were filed between 2013 and 20 July 2016. Of this, Indian citizens or organizations account for 39,318 while the number is 1, 05,742 for foreign nationals and organisations. Of the 12,442 applications filed in 2016-17, 3,248 are Indian applicants and […]
On May 12, 2016 the USPTO issued a Memorandum to the Patent Examining Corps on patent eligibility in view of recent court decisions. (Enfish, LLC v. Microsoft Corp. and TLI Communications LLC v. A. V Automotive, LLC) These decisions and the memo will be informative on how the courts and the USPTO determine the subject matter eligibility, and may bring some clarity regarding the eligibility […]
In a press release dated May 6th 2016, NASA has released 56 formerly patent technologies into the public domain, making its government developed technologies freely available for unrestricted commercial use. These technologies were developed to advance NASA missions but may have non-aerospace applications and be used by commercial space ventures and other companies free of charge, eliminating the time, expense […]
India has decided against giving the compulsory licence for Anglo-Swedish drugmaker AstraZeneca’s key antidiabetes compound Saxagliptin sought by Hyderabad-based Lee Pharma. The Controller of Patents office rejected the application on the grounds that substitutes to the drug are readily available in the market and Lee Pharma’s claim that requirements of public with respect to the patented invention are not being […]
Indian Patent office in an Order Dated: 31/12/2015, has streamlined numbering system of Patent applications and also request for examination filed. This numbering system will be implemented from 1st Jan 2016. According to the new numbering system the patent applications shall have 12 characters length with format YYYYJTNNNNNN, where YYYY denotes year of filing, J denotes jurisdiction (1: Delhi 2: […]
Patent wars that plagued the early years of the smartphone industry moved a big step closer to resolution on October 30, 2015, as Google and Microsoft reached a settlement to end some 20 patent lawsuits. In a joint statement, the two companies declared: “Microsoft and Google are pleased to announce an agreement on patent issues. As part of the agreement, the companies will dismiss […]
The government on Thursday 29th Oct 2015, proposed amendments to the rules under the Patents Act to streamline the application process, as part of its efforts to improve the ease of doing business in India. The Indian Patent Amendments (Amendment Rules), 2015 released by the Department of Industrial Policy and Promotion (DIPP) on Thursday seeks to fast-track the patent application […]
New Molecular Entity Drug Name Active Ingredient Date FDA-approved use on approval date Aristada aripiprazole lauroxil 10/6/2015 To treat adults with schizophrenia Tresiba insulin degludec injection 9/25/2015 To improve blood sugar (glucose) control in adults with diabetes mellitus Lonsurf trifluridine and tipiracil 9/22/2015 To treat patients with an advanced form of colorectal cancer who are no longer responding to other […]
Swiss pharmaceutical firm Helsinn Healthcare SA on October 13th 2015 said it has settled patent litigations relating to its anti-nausea injection Aloxi with Dr. Reddy’s Laboratories Ltd. The settlement will allow Dr. Reddy’s to market the generic version of Aloxi in the US on 30 September 2018 or earlier under certain circumstances, Helsinn said in a statement.The terms of the settlement […]